ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

In Brief: NIH Call For Review Group Nominations Brings 8,000 Names For 400 Vacancies

August 17, 1979

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

Cancer Meetings Listed For Next Three Months

September 20, 1996

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981